Viewing StudyNCT00352898



Ignite Creation Date: 2024-05-05 @ 4:56 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00352898
Status: COMPLETED
Last Update Posted: 2016-10-07
First Post: 2006-07-14

Brief Title: Immunogenicity Safety of Measles-mumps-rubella-varicella Vaccine MeMuRu-OKA Compared to Priorix Given With Varilrix
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Varicella
Mumps
Rubella
Measles
Keywords: